Cargando…

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

With up to 500,000 infections annually, Lassa virus (LASV), the cause of Lassa fever, is one of the most prevalent etiological agents of viral hemorrhagic fever (VHF) in humans. LASV is endemic in several West African countries with sporadic cases and prolonged outbreaks observed most commonly in Si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safronetz, David, Rosenke, Kyle, Westover, Jonna B., Martellaro, Cynthia, Okumura, Atsushi, Furuta, Yousuke, Geisbert, Joan, Saturday, Greg, Komeno, Takashi, Geisbert, Thomas W., Feldmann, Heinz, Gowen, Brian B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600983/ https://www.ncbi.nlm.nih.gov/pubmed/26456301 http://dx.doi.org/10.1038/srep14775

Ejemplares similares

Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018)

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015)

Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin
por: Lingas, Guillaume, et al.
Publicado: (2021)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015)

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
por: FURUTA, Yousuke, et al.
Publicado: (2017)

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
por: Yamada, Kentaro, et al.
Publicado: (2016)

Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011)

Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis
por: Ranadheera, Charlene, et al.
Publicado: (2020)

ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge
por: Fischer, Robert J., et al.
Publicado: (2021)

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
por: Furuta, Yousuke, et al.
Publicado: (2009)

Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virus
por: Kato, Hirofumi, et al.
Publicado: (2021)

Animal models for highly pathogenic emerging viruses
por: Safronetz, David, et al.
Publicado: (2013)

Domestic Pig Unlikely Reservoir for MERS-CoV
por: de Wit, Emmie, et al.
Publicado: (2017)

A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs
por: Stein, Derek R., et al.
Publicado: (2019)

Development of a New Vaccine for the Prevention of Lassa Fever
por: Geisbert, Thomas W, et al.
Publicado: (2005)

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Lassa Virus Treatment Options
por: Hansen, Frederick, et al.
Publicado: (2021)

A Sporadic and Lethal Lassa Fever Case in Forest Guinea, 2019
por: Magassouba, N’Faly, et al.
Publicado: (2020)

Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
por: Gowen, Brian B., et al.
Publicado: (2013)

Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration
por: Tani, Hideki, et al.
Publicado: (2018)

Lassa antiviral LHF-535 protects guinea pigs from lethal challenge
por: Cashman, Kathleen A., et al.
Publicado: (2022)

Favipiravir (T-705) Protects IFNAR(−/−) Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner
por: Matz, Keesha, et al.
Publicado: (2021)

Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out Mice
por: Marzi, Andrea, et al.
Publicado: (2018)

Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice
por: Westover, Jonna B., et al.
Publicado: (2019)

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
por: Cross, Robert W., et al.
Publicado: (2016)

Favipiravir (T-705) protects against Nipah virus infection in the hamster model
por: Dawes, Brian E., et al.
Publicado: (2018)

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
por: Mendenhall, Michelle, et al.
Publicado: (2011)

An Outbred Guinea Pig Disease Model for Lassa Fever Using a Host-Adapted Clade III Nigerian Lassa Virus
por: Deschambault, Yvon, et al.
Publicado: (2023)

Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA
por: Ursic-Bedoya, Raul, et al.
Publicado: (2014)

Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates
por: Stein, Derek R., et al.
Publicado: (2021)

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
por: Matassov, Demetrius, et al.
Publicado: (2015)

Detection of Lassa Virus, Mali
por: Safronetz, David, et al.
Publicado: (2010)

Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge
por: Sorvillo, Teresa E., et al.
Publicado: (2021)

Viral RNA and infectious virus in mucosal specimens from guinea pigs modelling early phases of lethal and non-lethal Lassa fever
por: Welch, Stephen R., et al.
Publicado: (2022)

Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali
por: Sogoba, Nafomon, et al.
Publicado: (2016)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus
por: Cross, Robert W., et al.
Publicado: (2023)

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys
por: Geisbert, Joan B, et al.
Publicado: (2020)

Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever
por: Caroline, Amy L., et al.
Publicado: (2014)

Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation
por: Maruyama, Junki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mdpfs99eooorqji91he1n5bbm4